Literature DB >> 2375690

The prognosis in Alzheimer's disease. 'How far' rather than 'how fast' best predicts the course.

D A Drachman1, B F O'Donnell, R A Lew, J M Swearer.   

Abstract

Clinical features at the initial examination of 42 patients with probable Alzheimer's disease were tested for prognostic value at subsequent follow-up of 54 +/- 25 months. These potential prognostic features were of three types: degree of severity features (eg, IQ scores); variable clinical features (eg, extrapyramidal signs); and individual distinguishing features (eg, gender, education, and age). The power of these potential prognostic features to predict prognosis was assessed using the Kaplan-Meier life-tables method and the Cox proportional hazards model. Three clinical end points were considered: total dependence in activities of daily living; incontinence; and institutionalization at follow-up. Degree of severity features (subtests of the Wechsler Adult Intelligence Scale-Revised and the Wechsler Memory Scale, and the Clinical Severity Score) predicted subsequent dependence in activities of daily living, incontinence, and institutionalization. Historical disease duration, age, gender, family history of dementia, retrospective rate of progression, anxiety, psychosis, depression, and extrapyramidal signs did not influence prognosis. These results suggest that initial degree of severity ("how far") rather than variation in the rate of progression ("how fast") best predicts prognosis in the early to intermediate stages of Alzheimer's disease. The relationship of disease severity to prognosis should be taken into account before concluding that there are subtypes of Alzheimer's disease that have different rates of progression.

Entities:  

Mesh:

Year:  1990        PMID: 2375690     DOI: 10.1001/archneur.1990.00530080033007

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  15 in total

1.  Expanding the ecological validity of WAIS-IV and WMS-IV with the Texas functional living scale.

Authors:  Lisa Whipple Drozdick; C Munro Cullum
Journal:  Assessment       Date:  2010-10-04

2.  Cognitive predictors of functional decline in vascular dementia.

Authors:  Angela L Jefferson; Deborah Cahn-Weiner; Patricia Boyle; Robert H Paul; David J Moser; Norman Gordon; Ronald A Cohen
Journal:  Int J Geriatr Psychiatry       Date:  2006-08       Impact factor: 3.485

3.  Higher working memory predicts slower functional decline in autopsy-confirmed Alzheimer's disease.

Authors:  Jagan A Pillai; Aaron Bonner-Jackson; Esteban Walker; Lyla Mourany; Jeffrey L Cummings
Journal:  Dement Geriatr Cogn Disord       Date:  2014-06-04       Impact factor: 2.959

4.  Delusions and hallucinations are associated with worse outcome in Alzheimer disease.

Authors:  Nikolaos Scarmeas; Jason Brandt; Marilyn Albert; Georgios Hadjigeorgiou; Alexandros Papadimitriou; Bruno Dubois; Maria Sarazin; Davangere Devanand; Lawrence Honig; Karen Marder; Karen Bell; Domonick Wegesin; Deborah Blacker; Yaakov Stern
Journal:  Arch Neurol       Date:  2005-10

5.  Motor signs predict poor outcomes in Alzheimer disease.

Authors:  N Scarmeas; M Albert; J Brandt; D Blacker; G Hadjigeorgiou; A Papadimitriou; B Dubois; M Sarazin; D Wegesin; K Marder; K Bell; L Honig; Y Stern
Journal:  Neurology       Date:  2005-05-24       Impact factor: 9.910

Review 6.  Systematic review of strengths and limitations of randomized controlled trials for non-pharmacological interventions in mild cognitive impairment: focus on Alzheimer's disease.

Authors:  T Horr; B Messinger-Rapport; J A Pillai
Journal:  J Nutr Health Aging       Date:  2015-02       Impact factor: 4.075

7.  Motor signs during the course of Alzheimer disease.

Authors:  N Scarmeas; G M Hadjigeorgiou; A Papadimitriou; B Dubois; M Sarazin; J Brandt; M Albert; K Marder; K Bell; L S Honig; D Wegesin; Y Stern
Journal:  Neurology       Date:  2004-09-28       Impact factor: 9.910

8.  Mediterranean diet and Alzheimer disease mortality.

Authors:  Nikolaos Scarmeas; Jose A Luchsinger; Richard Mayeux; Yaakov Stern
Journal:  Neurology       Date:  2007-09-11       Impact factor: 9.910

9.  Should EOAD patients be included in clinical trials?

Authors:  Kinga Szigeti; Rachelle S Doody
Journal:  Alzheimers Res Ther       Date:  2011-02-08       Impact factor: 6.982

10.  Urinary Incontinence, Incident Parkinsonism, and Parkinson's Disease Pathology in Older Adults.

Authors:  Noa M Buchman; Sue E Leurgans; Raj J Shah; Veronique VanderHorst; Robert S Wilson; Yaacov G Bachner; David Tanne; Julie A Schneider; David A Bennett; Aron S Buchman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-09-01       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.